Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLORY-2 phase 3 study of mazdutide 9 mg in Chinese adults with obesity
CTR20233902Phase 3Active
- Sponsor
- Innovent Biologics
- Start
- Dec 2023
- Modality
- Hormonal Peptides → Native Peptides → Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of mazdutide in obesity, sponsored by Innovent Biologics. Started Dec 2023; status: active.
02
Drugs
mazdutide
03
Conditions
obesity
Beyond the preview
Go deeper on CTR20233902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233902.